Description
A dual-component research blend pairing two widely studied peptides for laboratories comparing signaling readouts in vitro.
- Includes BPC-157 10 mg
- Includes TB-500 10 mg
- Dual-component blend for controlled in-vitro research
$129.00
Dual-peptide research blend for controlled in-vitro research models.
Discount per quantity
| Quantity | 5 - 9 | 10+ |
|---|---|---|
| Discount | 5% | 10% |
| Unit price | $122.55 | $116.10 |
Line total
$129.00
A dual-component research blend pairing two widely studied peptides for laboratories comparing signaling readouts in vitro.
| Format | Lyophilized powder |
|---|---|
| Components | BPC-157 10 mg, TB-500 10 mg |
| Purity (typical) | ≥99% by HPLC (batch COA applies) |
| Storage | Sealed, cool, dry, away from light |
BPC-157 and TB-500 (thymosin beta-4 fragment) are common subjects in soft-tissue and cell-migration research. Experimental design should avoid therapeutic claims.
Blend products simplify procurement for studies that require both compounds under one SKU; analytical verification remains the responsibility of the receiving lab.
For research, laboratory, or analytical purposes only.

An investigational peptide studied in metabolic research models. It is characterized in laboratory settings for receptor-signaling research and is supplied for in-vitro and analytical work only.

A mitochondrial-derived peptide studied for its role in cellular energy regulation and metabolic research. MOTS-c is a common reference compound in mitochondrial biology and aging-related studies.

A synthetic peptide studied for its role in endocrine research pathways. It is a common reference compound in metabolic and endocrine research models.

A synthetic fragment of a naturally occurring peptide involved in cellular migration research. TB-500 is a common reference compound in cell-motility research models.